CYCLERION THERAPEUTICS, INC. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+48.3% +$903K
$-968K
Free Cash Flow↑+48.3% +$903K
$-968K
Investing Cash Flow
$0
Financing Cash Flow
$251K
Capex
—
Stock-Based Comp↓-22.1% -$27K
$95K
D&A
—
SBC Allocated Expense↓-22.1% -$27K
$95K